Hinojosa-Amaya, J. M.
Varlamov, E. V.
Yedinak, C. G.
Cetas, J. S.
McCartney, S.
Banskota, S.
Fleseriu, M. http://orcid.org/0000-0001-9284-6289
Article History
Received: 29 January 2021
Accepted: 13 April 2021
First Online: 24 April 2021
Declarations
:
: José Miguel Hinojosa-Amaya, Elena Varlamov, Justin Cetas, Shirley McCartney, Swechya Banskota have no disclosures and no conflict of interest; Christine Yedinak disclosure–consultant for Chiasma; Maria Fleseriu disclosures–principal investigator with research support to Oregon Health & Science University for clinical research studies with Novartis, Ionis, Crinetics, Chiasma and Pfizer, and she has been an occasional scientific consultant for Novartis, Ionis, Ipsen, Crinetics, Chiasma, Recordati and Pfizer.
: The Oregon Health & Science University institutional review board approved this human subject research.
: The study was institutional review board approved with a waiver of authorization.